Olayemi Olubowale

Internal Medicine physician in Boston, Massachusetts — also lists obesity medicine in the CMS registry.

Practice Details

Address
50 Staniford St Ste 430
Boston, MA 02114
Geocoded location: 42.3626, -71.0638
Taxonomy
Internal Medicine
Credential
MD
NPPES Enumeration
Listed with NPPES since 2022
Sole Proprietor
No
Provider Gender (NPPES)
Male
Also Listed As
Yemi Olubowale
NPPES Record Updated
February 2026

Specialty taxonomies on file (2)

  • Internal Medicine
    Primary
  • Bariatric Surgery
    Internal Medicine, Obesity Medicine

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Olayemi Olubowale is an Internal Medicine physician in Boston whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 3660 Internal Medicine practices in Boston carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • A discussion of GLP-1 options for diabetes and/or weight management.
  • A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Olayemi Olubowale's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 617-726-4400.

GLP-1 access in Boston, Massachusetts

Adult obesity rate
27.2%
#47 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$229/mo
Typical Massachusetts telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Massachusetts Medicaid, obesity indication

About 27.2% of Massachusetts adults have obesity (BMI 30+), ranking the state #47 of 50 (CDC BRFSS). Our directory currently lists 330 GLP-1-relevant clinics in Boston. If a cash-pay route makes more sense, compounded semaglutide through Massachusetts telehealth averages about $229/mo — well below brand-name Wegovy or Zepbound.

Explore more Massachusetts options on the best Massachusetts GLP-1 providers page, browse every Boston listing in the Boston clinic directory, or read the Massachusetts Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Boston

Other Boston listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Massachusetts addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Massachusetts telehealth partners:

Featured Partners · Boston

Featured GLP-1 providers serving Boston

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Boston options on the Boston clinic directory, our Boston GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Boston obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Olayemi Olubowale's specialty taxonomy but not the specific medications it prescribes or its current service menu. Olayemi Olubowale is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 617-726-4400 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Olayemi Olubowale's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Olayemi Olubowale is located at 50 Staniford St Ste 430, Boston, MA 02114. The phone number listed in the registry is 617-726-4400. Its full record is public in the CMS National Provider registry under NPI 1528701620.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Olayemi Olubowale is currently accepting new patients. Call the practice at 617-726-4400 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.